Table 1.
Total Patients, n (%) | |
---|---|
Maternal count | 358 (100) |
Antepartum cases with fetal outcome | 68 (84.0) |
Average maternal age, y (SD) | 29.5 (6.1) |
Median gravity/parity (range) | 2/1 (G1P0–G9P8) |
Median gestational age (SD) | 24 wk (6.2) |
Interquartile range | 6.14 wk |
Stage of pregnancy, n (%) | |
Antepartum | 81 (22.6) |
Immediate postpartum | 69 (19.3) |
Postpartum | 126 (35.2) |
Uncategorized | 82 (22.9) |
Delivery type, n (%) | |
Vaginal | 67 (18.7) |
Cesarean | 158 (44.1) |
Dilation and extraction | 5 (1.4) |
Not reported | 128 (35.8) |
Deliveries on extracorporeal membrane oxygenation, n (%) | 35 (9.8) |
Extracorporeal life support indications, n (%)a | |
Acute respiratory distress syndrome | 177 (49.4) |
Cardiac failure | 67 (18.7) |
Cardiac arrest | 57 (15.9) |
Peripartum cardiomyopathy | 45 (12.6) |
Pulmonary arterial hypertension | 28 (7.8) |
Amniotic fluid embolism | 27 (7.5) |
Pulmonary embolism | 17 (4.7) |
Heart disease | 14 (3.9) |
Septic shock | 11 (3.1) |
Asthma | 7 (2.0) |
Malignancy | 7 (2.0) |
Takotsubo cardiomyopathy | 6 (1.7) |
Pheochromocytoma | 5 (1.4) |
Spontaneous coronary artery dissection | 3 (0.8) |
Aspiration pneumonitis | 2 (0.6) |
Trauma | 2 (0.6) |
Distributive shock | 1 (0.3) |
Propofol infusion syndrome | 1 (0.3) |
Hemorrhagic shock | 1 (0.3) |
Diffuse alveolar hemorrhage | 1 (0.3) |
Pulmonary alveolar proteinosis | 1 (0.3) |
Interstitial lung disease | 1 (0.3) |
Sickle cell crisis | 1 (0.3) |
Aortic dissection | 1 (0.3) |
Transfusion related acute lung injury | 1 (0.3) |
Cerebral venous thrombosis | 1 (0.3) |
Pulmonary hemorrhage | 1 (0.3) |
Cystic fibrosis | 1 (0.3) |
Dengue fever | 1 (0.3) |
Extracorporeal membrane oxygenation cannulation mode, n (%) | |
Venoarterial | 145 (40.5) |
Venovenous | 96 (26.8) |
Both venoarterial and venovenous | 19 (5.3) |
Not reported | 98 (27.4) |
Maternal overall survival at 30 d, n (%) | 270 (75.4) |
Antepartum | 65 (81.2) |
Immediate postpartum | 58 (84.1) |
Postpartum | 85 (67.5) |
Timeframe unspecified | 62 (75.6) |
Maternal overall survival at 1 y, n (%) | 266 (74.3) |
Maternal complications, n (%)b | |
Mild to moderate bleeding | 66 (18.4) |
Severe bleeding requiring surgical intervention (laparotomy, hysterectomy) | 48 (13.4) |
Intracranial neurologic morbidity | 19 (5.3) |
Vascular complications (extremity ischemia, infection) | 14 (3.9) |
Deep vein thrombosis | 10 (2.8) |
Other (peripheral neuropathy, need for rehabilitation on discharge, hyperbilirubinemia, reperfusion injury, bradycardia with cannulation) | 22 (6.1) |
Fetal survival, n (%) | 44 (64.7) |
Fetal complications, n (%)b | |
Preterm delivery | 33 (48.5) |
Neonatal intensive care unit admission | 19 (27.9) |
Some cases had multiple indications for ECLS.
Some cases had multiple complications.